{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:53:04Z","timestamp":1781578384278,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijid.2026.108733","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:43:35Z","timestamp":1777131815000},"page":"108733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human papillomavirus: Role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa"],"prefix":"10.1016","volume":"169","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8547-3153","authenticated-orcid":false,"given":"Christian","family":"Tague","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9067-6605","authenticated-orcid":false,"given":"Ayesha","family":"Junaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8012-6654","authenticated-orcid":false,"given":"Yousra","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4383-8976","authenticated-orcid":false,"given":"Sarah","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1246-1491","authenticated-orcid":false,"given":"Dhruv","family":"Gehlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1160-8887","authenticated-orcid":false,"given":"Afsheen","family":"Azhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5254-5909","authenticated-orcid":false,"given":"Zainab Abdul","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1770-2685","authenticated-orcid":false,"given":"Simran","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0398-432X","authenticated-orcid":false,"given":"Johan Armel","family":"Domga Kaptso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0262-7568","authenticated-orcid":false,"given":"Germain","family":"Cebweru Murhola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6088-2629","authenticated-orcid":false,"given":"Criss","family":"Koba Mjumbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108733_bib0001","unstructured":"Cervical cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Accessed October 10, 2025."},{"key":"10.1016\/j.ijid.2026.108733_bib0002","unstructured":"Cancer Today. https:\/\/gco.iarc.who.int\/today\/. Accessed October 10, 2025."},{"key":"10.1016\/j.ijid.2026.108733_bib0003","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ijgc-2022-003957","article-title":"Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services","volume":"33","author":"Dzinamarira","year":"2023","journal-title":"Int J Gynecol Cancer J Int Gynecol Cancer Soc"},{"issue":"Suppl 7","key":"10.1016\/j.ijid.2026.108733_bib0004","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1016\/j.vaccine.2013.10.003","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108733_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pr Res Clin Obs Gynaecol"},{"key":"10.1016\/j.ijid.2026.108733_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122488","article-title":"Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis","volume":"10","author":"Ogembo","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2026.108733_bib0007","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS L Engl"},{"key":"10.1016\/j.ijid.2026.108733_bib0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.1822","article-title":"Human papillomavirus molecular biology and disease association","volume":"25 Suppl 1","author":"Doorbar","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.ijid.2026.108733_bib0009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines \u2013 a review of the first decade","volume":"146","author":"Harper","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijid.2026.108733_bib0010","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet L Engl"},{"key":"10.1016\/j.ijid.2026.108733_bib0011","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108733_bib0012","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","article-title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","volume":"395","author":"Brisson","year":"2020","journal-title":"Lancet L Engl"},{"key":"10.1016\/j.ijid.2026.108733_bib0034","first-page":"55","article-title":"H.uman papillomavirus genotype distribution patterns in Zimbabwe; is the bivalent vaccine sufficient?","volume":"67","author":"Marembo","year":"2024","journal-title":"Intervirology"},{"key":"10.1016\/j.ijid.2026.108733_bib0028","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4161\/hv.5.10.9518","article-title":"Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years","volume":"5","author":"Einstein","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.ijid.2026.108733_bib0032","series-title":"Screening for Cervical Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force","author":"Vesco","year":"2011"},{"key":"10.1016\/j.ijid.2026.108733_bib0013","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1186\/s12885-019-5781-3","article-title":"Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review","volume":"19","author":"Lekoane","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijid.2026.108733_bib0014","doi-asserted-by":"crossref","first-page":"e1101","DOI":"10.1016\/S2214-109X(25)00065-8","article-title":"Changes in incidence of HPV-related cancers in South Africa (2011\u201321): a cross-sectional analysis of the South African National Cancer Registry","volume":"13","author":"Shing","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26021","article-title":"Modelling cervical cancer elimination using single-visit screening and treatment strategies in the context of high HIV prevalence: estimates for KwaZulu-Natal, South Africa","volume":"25","author":"Rao","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.ijid.2026.108733_bib0016","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/09564624251315787","article-title":"High unmet needs for cervical cancer screening among women living with HIV in six African countries: a population-based study","volume":"36","author":"Alpar","year":"2025","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijid.2026.108733_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003528","article-title":"Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: a cohort study","volume":"18","author":"Kelly","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2026.108733_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163965","article-title":"Epidemiology of HPV genotypes among HIV positive women in Kenya: a systematic review and meta-analysis","volume":"11","author":"Menon","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2026.108733_bib0019","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.32260","article-title":"Cervical cancer risk in women living with HIV across four continents: a multicohort study","volume":"146","author":"Rohner","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2026.108733_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043941","article-title":"Cancer in HIV-positive and HIV-negative adolescents and young adults in South Africa: a cross-sectional study","volume":"11","author":"Dhokotera","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2026.108733_bib0022","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A. review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30 Suppl 5","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108733_bib0023","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2026.108733_bib0024","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","article-title":"Pathology and epidemiology of HPV infection in females","volume":"117","author":"Stanley","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijid.2026.108733_bib0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2010.08.003","article-title":"In vivo mechanisms of vaccine-induced protection against HPV infection","volume":"8","author":"Day","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijid.2026.108733_bib0026","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijid.2026.108733_bib0027","first-page":"6186","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol Balt Md 1950"},{"key":"10.1016\/j.ijid.2026.108733_bib0029","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet L Engl"},{"key":"10.1016\/j.ijid.2026.108733_bib0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijid.2026.108733_bib0031","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.ijid.2026.108733_bib0033","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0140-6736(17)31821-4","article-title":"Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial","volume":"390","author":"Huh","year":"2017","journal-title":"Lancet L Engl"},{"issue":"39","key":"10.1016\/j.ijid.2026.108733_bib0035","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1016\/j.vaccine.2014.06.038","article-title":"Efficacy of the HPV-16\/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16\/18 vaccine trial","volume":"32","author":"Hildesheim","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108733_bib0036","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against Human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108733_bib0037","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against Human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108733_bib0038","doi-asserted-by":"crossref","first-page":"100401","DOI":"10.1016\/j.eclinm.2020.100401","article-title":"Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries","volume":"23","author":"Kjaer","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ijid.2026.108733_bib0039","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2026.108733_bib0040","doi-asserted-by":"crossref","first-page":"e1096","DOI":"10.1016\/S2214-109X(23)00193-6","article-title":"Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys","volume":"11","author":"Sayinzoga","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0041","doi-asserted-by":"crossref","first-page":"e1473","DOI":"10.1016\/S2214-109X(22)00309-6","article-title":"Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial","volume":"10","author":"Watson-Jones","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0042","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","article-title":"Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results","volume":"29","author":"Barnabas","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2026.108733_bib0043","unstructured":"Human papillomavirus. https:\/\/www.gavi.org\/types-support\/vaccine-support\/human-papillomavirus (2025). Accessed October 10, 2025."},{"key":"10.1016\/j.ijid.2026.108733_bib0044","unstructured":"Human papillomavirus (HPV) vaccination coverage. https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/human-papillomavirus-(hpv)-vaccination-coverage. Accessed October 10, 2025."},{"key":"10.1016\/j.ijid.2026.108733_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177773","article-title":"Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries","volume":"12","author":"Gallagher","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ijid.2026.108733_bib0046","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2471\/BLT.11.097253","article-title":"Achieving high coverage in Rwanda\u2019s national human papillomavirus vaccination programme","volume":"90","author":"Binagwaho","year":"2012","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2026.108733_bib0047","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.12186","article-title":"Progress in HPV vaccination in low- and lower-middle-income countries","volume":"138","author":"LaMontagne","year":"2017","journal-title":"Int J Gynaecol Obs Organ Int Fed Gynaecol Obs"},{"key":"10.1016\/j.ijid.2026.108733_bib0048","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182663","article-title":"Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects","volume":"12","author":"Botwright","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2026.108733_bib0049","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2025.1892","article-title":"Factors associated with human papilloma virus vaccine uptake before the health awareness, learning and education intervention in Korogocho Informal Settlements in Nairobi County, Kenya","volume":"19","author":"Ogolla","year":"2025","journal-title":"ecancermedicalscience"},{"issue":"12","key":"10.1016\/j.ijid.2026.108733_bib62","first-page":"2157","article-title":"The HPV vaccine: an analysis of the FUTURE II study","volume":"53","author":"Howard","year":"2007","journal-title":"Can. Fam. Physician."},{"key":"10.1016\/j.ijid.2026.108733_bib0052","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003006","article-title":"Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries","volume":"5","author":"Ochalek","year":"2020","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0053","doi-asserted-by":"crossref","first-page":"101734","DOI":"10.1016\/j.pmedr.2022.101734","article-title":"Cost and effectiveness of HPV vaccine delivery strategies: a systematic review","volume":"26","author":"Akumbom","year":"2022","journal-title":"Prev Med Rep"},{"issue":"1","key":"10.1016\/j.ijid.2026.108733_bib0054","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12889-023-15842-1","article-title":"Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review","volume":"23","author":"Kutz","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0055","doi-asserted-by":"crossref","first-page":"1112981","DOI":"10.3389\/fpubh.2023.1112981","article-title":"Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: what works in the context of low-resource countries?","volume":"11","author":"Waheed","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0056","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s41256-024-00380-z","article-title":"Accelerating HPV vaccination in Africa for health equity","volume":"9","author":"Asempah","year":"2024","journal-title":"Glob Health Res Policy"},{"key":"10.1016\/j.ijid.2026.108733_bib0057","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022072","article-title":"Effects of a multidisciplinary team-led school-based human papillomavirus vaccination health-promotion programme on improving vaccine acceptance and uptake among female adolescents: a cluster randomized controlled trial","volume":"99","author":"Chau","year":"2020","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.ijid.2026.108733_bib0058","unstructured":"WHO. Essential Programme on Immunization. Visited on 01\/11\/2025. available at: https:\/\/www.who.int\/teams\/immunization-vaccines-and-biologicals\/essential-programme-on-immunization."},{"key":"10.1016\/j.ijid.2026.108733_bib0059","author":"Fisher"},{"key":"10.1016\/j.ijid.2026.108733_bib0060","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/07448481.2022.2044823","article-title":"A community-based, interdisciplinary approach to improving HPV vaccine uptake at a large urban public university","volume":"72","author":"Yahia","year":"2024","journal-title":"J Am Coll Health"},{"key":"10.1016\/j.ijid.2026.108733_bib0061","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/vaccines6030061","article-title":"Prevention of cervical cancer in Sub-Saharan Africa: the advantages and challenges of HPV vaccination","volume":"6","author":"Black","year":"2018","journal-title":"Vaccines"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:39:17Z","timestamp":1781577557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226003681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"alternative-id":["S1201971226003681"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108733","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus: Role of HPV2 and HPV9 in reducing the burden of cervical cancer in sub-Saharan Africa","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108733"}}